This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bjerkvig, R. Articles by Rucklidge, G. J. Search for Related Content PubMed PubMed Citation Articles by Bjerkvig, R. Articles by Rucklidge, G. J.

Immunocytochemical Characterization of Extracellular Matrix Proteins Expressed by Cultured Glioma Cells¹

The Gade Institute, Department of Pathology, University of Bergen, N-5021 Haukeland Hospital, Bergen, Norway [R. B., O. D. L.], and The Rowett Research Institute, Greenburn Road, Bucksburn, Aberdeen AB2 9SB, Scotland [G. J. R.]

The immunolocalization of type I, III and IV collagens and fibronectin in two rat glioma cell lines in vitro (BT4C and BT4Cn) is described. In addition, antibodies against denatured type I and III collagens were used to study breakdown products of native type I and III collagens. For the BT4C cells, the extracellular matrix expression in monolayer cultures and in multicellular tumor spheroids was compared. Type IV collagen was strongly expressed in BT4C tumor spheroids but was negative in the corresponding monolayer cultures. Denatured type I collagen was found both in monolayers and in spheroids of BT4C, suggesting either a rapid turnover (i.e., synthesis and immediate breakdown) of type I collagen or an altered collagen gene transcription. Both cell lines were negative for native type I and III and denatured type III collagen.

Fibronectin was strongly expressed in both cell lines.

Supporting the immunofluorescence data, the hydroxyproline content in the tumor spheroids was twice the amount found in monolayer cultures. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis combined with immunoblotting also verified the immunostaining experiments, showing that glioma spheroids and injected tumor cells have the potential for fibronectin and collagen production, given the appropriate growth conditions.

¹ Supported by the Norwegian Cancer Society and by a FEBS fellowship.

² To whom requests for reprints should be addressed.

Received 9/13/88. Revised 4/17/89. Accepted 6/29/89.